These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14408331)

  • 1. [Clinical studies on a nor-sympathomimetic (beta-p-hydroxyphenylisopropylamine hydrobromide)].
    KADEN W; ANGER G
    Bruns Beitr Klin Chir; 1959; 199():396-407. PubMed ID: 14408331
    [No Abstract]   [Full Text] [Related]  

  • 2. Paredrine hydrobromide; intraocular pressure evaluations.
    DARLEY LH; KOCH FL; LEVATIN P
    Trans Am Ophthalmol Soc; 1955; 53():255-62; discussion, 262-4. PubMed ID: 13360880
    [No Abstract]   [Full Text] [Related]  

  • 3. Paredrine hydrobromide in chronic conjunctivitis.
    LIPSIUS EI
    Am J Ophthalmol; 1952 Nov; 35(11):1692-4. PubMed ID: 12996629
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of some adrenolytic drugs on arterial experimental hypertension induced by beta-4-hydroxyphenylisopropylamine.
    PENNETTI V; STRANO A; CAMPA PP; ANGRISANI G
    Arch Int Pharmacodyn Ther; 1960 May; 125():272-86. PubMed ID: 13854273
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
    Simpson LL
    J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of guanethidine by dexamphetamine and other related sympathomimetic amines.
    DAY MD; RAND MJ
    J Pharm Pharmacol; 1962 Sep; 14():541-9. PubMed ID: 13884062
    [No Abstract]   [Full Text] [Related]  

  • 7. [Particular neurological effects provoked by a sympathomimetic amine].
    BENASSI P
    Riv Neurol; 1955; 25(5):817-23. PubMed ID: 13298515
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate.
    Danielson TJ; Boulton AA
    Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination and identification of p-hydroxyamphetamine as the O, N-diacetyl derivative.
    WELSH LH; SUMMA AF
    J Pharm Sci; 1963 Jul; 52():656-8. PubMed ID: 13999899
    [No Abstract]   [Full Text] [Related]  

  • 10. Formation of alpha-methyldopamine ("Catecholamphetamine") from p-hydroxyamphetamine by rat brain microsomes.
    Hoffman AR; Sastry BV; Axelrod J
    Pharmacology; 1979; 19(5):256-60. PubMed ID: 538080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate.
    Danielson TJ; Davis BA; Boulton AA
    Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effects of xylopropamine and pervitin on spider web-building].
    WITT PN
    Arch Int Pharmacodyn Ther; 1956 Nov; 108(2):143-52. PubMed ID: 13382388
    [No Abstract]   [Full Text] [Related]  

  • 13. SYMPATHOMIMETIC DRUG-INDUCED PSYCHOSIS.
    MURRAY PA
    J Ir Med Assoc; 1964 Jan; 54():21-3. PubMed ID: 14105269
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of the effectiveness of certain anorexigenic agents.
    FAZEKAS JF; EHRMANTRAUT WR; KLEH J
    Am J Med Sci; 1958 Dec; 236(6):692-9. PubMed ID: 13606123
    [No Abstract]   [Full Text] [Related]  

  • 15. The interaction of sympathomimetic pressor amines; inversion of the vonedrine pressor action by paredrine.
    AHLQUIST RP
    J Am Pharm Assoc Am Pharm Assoc; 1946 Nov; 35(11):348-50. PubMed ID: 20274504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychotonic amines; clinical use].
    GOSSET JR
    Concours Med; 1950 Sep; 72(36):2643-4. PubMed ID: 14773166
    [No Abstract]   [Full Text] [Related]  

  • 17. [ENHANCEMENT OF THE ABSOLUTE TOXICITY OF CERTAIN SYMPATHOMIMETIC AMINES BY THYROXIN].
    HALPERN B; DRUDI-BARACCO C; BESSIRARD D
    C R Hebd Seances Acad Sci; 1963 Aug; 257():1559-62. PubMed ID: 14083968
    [No Abstract]   [Full Text] [Related]  

  • 18. THE CATION-RETAINING ACTION OF SYMPATHOMIMETIC SUBSTANCES IN THE RAT.
    LLAURADO JG
    Chemotherapia (Basel); 1963; 5358():363-81. PubMed ID: 14044895
    [No Abstract]   [Full Text] [Related]  

  • 19. [AGGRAVATION BY THYROXIN OF EMOTIONAL REACTIONS INDUCED BY SYMPATHOMIMETIC AMINES AND DEFINED BY "GROUP TOXICITY"].
    HALPERN B; DRUDI-BARACCO C; BESSIRARD D
    C R Hebd Seances Acad Sci; 1963 Aug; 257():1641-3. PubMed ID: 14087415
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synergism and antagonism of some sympathomimetic amines towards noradrenaline in vitro. Study on isolated rat seminal vesicle. II].
    Valette G
    C R Seances Soc Biol Fil; 1974; 168(10-11-12):1230-3. PubMed ID: 4283078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.